Literature DB >> 31112365

A comparative study of HAMSCs/HBMSCs transwell and mixed coculture systems.

Yifeng Bian1, Yifei Du1,2, Ruixia Wang1,3, Ning Chen1,2, Xin Du4, Yuli Wang1,2, Hua Yuan1,2.   

Abstract

Our previous studies indicated that a coculture system containing human amnion-derived mesenchymal stem cells (HAMSCs) and human bone marrow mesenchymal stem cells (HBMSCs) has the potential of application for bone regeneration. However, there is currently no enough comparative investigation between HAMSCs/HBMSCs transwell and mixed coculture systems. This study aimed to assess the phenotype and mechanisms regulated by indirect and direct coculture systems, respectively. Two in vitro models were employed with HAMSCs and HBMSCs at a ratio of 3:1, and then were analyzed by a series of processes, including flow cytometry, alkaline phosphatase (ALP) substrate assays, Alizarin red S staining, quantitative reverse transcription polymerase chain reaction (RT-qPCR), and Western blot analysis. We found that cell proliferation, ALP activity, mineralized matrix formation, and osteoblast-related mRNA expression were accelerated in transwell coculture system compared with mixed coculture system. Conditioned medium from transwell coculture system achieved an elevated level of vascular endothelial growth factor and induced more vascular structures in human umbilical vein endothelial cells than those of mixed coculture system. Moreover, we observed that transwell coculture system, promoted osteogenesis and angiogenesis by maintaining stemness through extracellular regulated protein kinases 1/2 (ERK1/2) mitogen-activated protein kinase (MAPK) signaling pathway. U0126, a selective inhibitor of ERK1/2 MAPK signaling, significantly suppressed maintaining of the stemness-based effects on transwell coculture system. Taken together, our results compared the merits of two different models and clarified the role of HAMSCs/HBMSCs transwell coculture system in the development of bone tissue engineering.
© 2019 IUBMB Life, 2019. © 2019 International Union of Biochemistry and Molecular Biology.

Entities:  

Keywords:  coculture system; human amnion-derived mesenchymal stem cells; human bone marrow mesenchymal stem cells; mitogen-activated protein kinase signaling pathway; stemness

Mesh:

Substances:

Year:  2019        PMID: 31112365     DOI: 10.1002/iub.2074

Source DB:  PubMed          Journal:  IUBMB Life        ISSN: 1521-6543            Impact factor:   3.885


  6 in total

1.  Endothelial cell‑derived CCL15 mediates the transmigration of fibrocytes through the CCL15‑CCR1 axis in vitro.

Authors:  Nan Pang; Zhixiao Lin; Xiaolin Wang; Lirong Xu; Xiaoli Xu; Rong Huang; Xingxing Li; Xueyong Li; Jinqing Li
Journal:  Mol Med Rep       Date:  2020-10-19       Impact factor: 2.952

Review 2.  Human Amniotic Mesenchymal Stem Cells Promote Endogenous Bone Regeneration.

Authors:  Jin Li; Zhixuan Zhou; Jin Wen; Fei Jiang; Yang Xia
Journal:  Front Endocrinol (Lausanne)       Date:  2020-10-02       Impact factor: 5.555

Review 3.  Construction and imaging of a neurovascular unit model.

Authors:  Taiwei Dong; Min Li; Feng Gao; Peifeng Wei; Jian Wang
Journal:  Neural Regen Res       Date:  2022-08       Impact factor: 5.135

4.  Isolation and characterization mesenchymal stem cells from red panda (Ailurus fulgens styani) endometrium.

Authors:  Dong-Hui Wang; Xue-Mei Wu; Jia-Song Chen; Zhi-Gang Cai; Jun-Hui An; Ming-Yue Zhang; Yuan Li; Fei-Ping Li; Rong Hou; Yu-Liang Liu
Journal:  Conserv Physiol       Date:  2022-02-21       Impact factor: 3.252

5.  Machine Learning Identifies Pan-Cancer Landscape of Nrf2 Oxidative Stress Response Pathway-Related Genes.

Authors:  Na Li; Xianquan Zhan
Journal:  Oxid Med Cell Longev       Date:  2022-02-17       Impact factor: 6.543

6.  Semaphorin3A promotes osseointegration of titanium implants in osteoporotic rabbits.

Authors:  An Song; Feng Jiang; Yi Wang; Ming Wang; Yanhui Wu; Yang Zheng; Xiaomeng Song; Wei Zhang; Junbo Zhou
Journal:  Clin Oral Investig       Date:  2021-08-06       Impact factor: 3.573

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.